Sign up to save your podcasts
Or
Share GBM and Lomustine
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
GBM and Lomustine
Dr. Howard Colman discusses the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.
Show references: https://journals.lww.com/neurotodayonline/Fulltext/2021/09160/A_Glioblastoma_Drug_Is_Abruptly_Withdrawn_from.6.aspx
View all episodes
By American Academy of Neurology
4.8
132132 ratings
Dr. Howard Colman discusses the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.
Show references: https://journals.lww.com/neurotodayonline/Fulltext/2021/09160/A_Glioblastoma_Drug_Is_Abruptly_Withdrawn_from.6.aspx
More shows like Neurology Minute
View all
NEJM This Week
321 Listeners
JAMA Clinical Reviews
504 Listeners
Neurology® Podcast
299 Listeners
Practical Neurology Podcast
53 Listeners
Mayo Clinic Talks
298 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
JAMA Neurology Author Interviews
16 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
Neurology Today in 5
24 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
518 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Neurology Exam Prep Podcast
189 Listeners
Continuum Audio
80 Listeners